We are live on ! Find out more
CNSP icon

CNS Pharmaceuticals
CNSP

1 hedge funds and large institutions have $828K invested in CNS Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

42% less capital invested

Capital invested by funds: $1.44M → $828K (-$609K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$33K
2
HF
HRT Financial
New York
-$24K
3
SFP
Sterling Financial Planning
New Jersey
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$428K – – –
Renaissance Technologies
2
Renaissance Technologies
New York
$104K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$75K – – –
Citadel Advisors
4
Citadel Advisors
Florida
$58K – – –
BlackRock
5
BlackRock
New York
$29K – – –
Northern Trust
6
Northern Trust
Illinois
$23K – – –
Bank of New York Mellon
7
Bank of New York Mellon
New York
$21K – – –
Cambridge Investment Research Advisors
8
Cambridge Investment Research Advisors
Iowa
$18K – – –
Commonwealth Equity Services
9
Commonwealth Equity Services
Massachusetts
$14K – – –
State Street
10
State Street
Massachusetts
$13K – – –
TRCT
11
Tower Research Capital (TRC)
New York
$10K – – –
ACI
12
Alpha Cubed Investments
California
$8K – – –
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
$8K – – –
Wells Fargo
14
Wells Fargo
California
$8K – – –
Morgan Stanley
15
Morgan Stanley
New York
$4K – – –
UBS Group
16
UBS Group
Switzerland
$3K – – –
CAL
17
Capital Analysts LLC
Pennsylvania
$1K – – –
CA
18
CoreCap Advisors
Michigan
$1K – – –
GRP
19
Global Retirement Partners
California
$1K – – –
MIFH
20
Migdal Insurance & Financial Holdings
Israel
$1K – – –
HF
21
HRT Financial
New York
– -$24K – –
SFP
22
Sterling Financial Planning
New Jersey
– -$1K – –
VF
23
Virtu Financial
New York
– -$33K – –

CNSP Hedge Fund Activity: Q4 2021 in Review

1 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in CNS Pharmaceuticals (CNSP) for Q4 2021, worth a combined $828K — down 42% from $1.44M a quarter earlier.

Fund positioning in CNSP was balanced in Q4 2021: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Virtu Financial, cutting an estimated $33K.

  • 1 institutional investor held CNS Pharmaceuticals (CNSP) as of Q4 2021, unchanged from Q3 2021.
  • Funds reported $828K of CNS Pharmaceuticals stock for Q4 2021, down 42% quarter-over-quarter.
  • 0 funds opened new CNS Pharmaceuticals positions in Q4 2021 and 0 closed out.
  • The largest CNS Pharmaceuticals seller in Q4 2021 was Virtu Financial, an estimated $33K sold.

Based on aggregated 13F filings for Q4 2021.